Healthcare
Live Price
Offline$30.30
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Suzuken Co., Ltd. (SZUKF) is a Healthcare stock with a market cap of $376.66B and listed on OTC. The stock last traded around $30.30 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +0.6%, EPS growth of +27.0%, a dividend yield of 1.8%. What stands out right now is revenue +0.6%, EPS +27.0%, free cash flow -217.0% with operating margin 1.4% and ROIC 5.5%. The dividend is present but secondary, with a yield around 1.8%. Valuation is more restrained than many high-expectation growth names at P/E 11.0 and price/sales 0.2. Stock Foundry combines SZUKF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SZUKF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SZUKF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SZUKF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.1T
-4.7% YoY
FY Net Income
$7.9B
-45.1% YoY
Free Cash Flow
$7.7B
+262.2% YoY
Revenue Growth
+0.6%
EPS Growth
+27.0%
Gross Margin
7.8%
Net Margin
1.4%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2400.0B | 2386.5B | 2314.8B | 2232.8B | 2128.5B |
| Gross Profit | 192.2B | 185.2B | 179.7B | 161.0B | 157.8B |
| Operating Income | 37.1B | 34.9B | 32.6B | 20.1B | 9.2B |
| EBITDA | 62.4B | 51.4B | 39.5B | 32.6B | 22.9B |
| Net Income | 34.5B | 29.0B | 20.3B | 14.4B | 7.9B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 102.7B | 181.8B | 109.0B | 141.4B | 151.1B |
| Total Assets | 1113.8B | 1228.7B | 1146.1B | 1141.7B | 1114.4B |
| Total Liabilities | 706.4B | 812.3B | 734.6B | 723.7B | 696.5B |
| Shareholder Equity | 407.3B | 416.3B | 411.2B | 417.7B | 417.0B |
| Total Debt | 0 | 1.8B | 1.8B | 2.1B | 2.3B |
| Net Debt | -102.7B | -181.8B | -107.2B | -139.3B | -148.8B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
15.6B
+63.9% YoY
Capital Expenditures
7.9B
+45.0% YoY
Free Cash Flow
7.7B
+262.2% YoY
Key ratios
Gross Margin
7.8%
Operating Margin
1.4%
Net Margin
1.4%
ROE
8.6%
Debt / Equity
0.05x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.